跳至主要内容
临床试验/DRKS00013658
DRKS00013658已完成不适用

Sleep-disordered-breathing in patients with precapillary pulmonary hypertension

niversitätsklinikum Münster0 个研究点目标入组 80 人开始时间: 2018年3月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • a. Age > 18 years (no age limit)
  • b. able to consent
  • c. Diagnosis of Nizza class I pumonary arterial Hypertension -PAH- according to the most recent Guidelines of the European Society of Cardiology (ESC); >12 weeks since the diagnosis of PAH has been made; no hospitalisation for HF in the last 4 weeks; optimal medical therapy in accordance with the most recent Guidelines of the European Society of Cardiology (ESC) with no change in medication in the last 4 weeks and combination therapy for PAH -where there was no treatment with combination therapy in PAH patients then the reason must be documented

排除标准

  • - secondary (postcapillary) pulmonary hypertension (mean pulmonary arterial hypertension > 25 mmHg; PCWP >15 mmHg)
  • - other severe internistic pre-existing conditions, especially insulin-dependent diabetes or severe renal impairment
  • - severe neurological pre-existing conditions such as stroke, especially brainstem infarction
  • - intake of opioids
  • - psychiatric pre-existing conditions
  • - contraindications to (cardiac) magnetic resonance imaging (MRI)

研究者

发起方
niversitätsklinikum Münster

相似试验